Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance

被引：0
|
作者：
Onnekink, Anke M. [1 ,5 ]
Michiels, Nynke [2 ]
Klatte, Derk C. F. [1 ]
Oldenburg, Lotte [3 ]
Mieog, J. Sven D. [2 ]
Vahrmeijer, Alexander L. [2 ]
van Hooft, Jeanin E. [1 ]
van Leerdam, Monique E. [1 ,4 ]
Bonsing, Bert A. [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[3] Locat Univ Amsterdam, Amsterdam UMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Gastrointestinal Oncol, Amsterdam, Netherlands
[5] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
INTERNATIONAL STUDY-GROUP; COMPLICATIONS; DEFINITION;
D O I：
10.1093/bjs/znad430
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-Leiden)
    Cappel, WHDTN
    Offerhaus, GJA
    van Puijenbroek, M
    Caspers, E
    Gruis, NA
    de Snoo, FA
    Lamers, CBHW
    Griffioen, G
    Bergman, W
    Vasen, HFA
    Morreau, H
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3598 - 3605
  • [32] A CDKN2A (p16) Mutation AssociatedWith Familial Pancreatic Cancer Reduces Protein Stability and Functionality
    Horn, I. P.
    Marks, D. L.
    Hogenson, T. L.
    Almada, L. L.
    Goldstein, L. E.
    Duran, P. A. Romecin
    Vrabel, A. M.
    Cui, G.
    Chaffee, K. G.
    Bamlet, W. R.
    Mer, G.
    Li, H.
    Petersen, G. M.
    Fernandez-Zapico, M. E.
    PANCREAS, 2018, 47 (10) : 1393 - 1394
  • [33] Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
    Dacic, S.
    Poppei, H. H.
    Kothmaier, H.
    Halbwedt, I.
    Morbini, P.
    Murer, B.
    Comin, C. E.
    Galateau-Salle, F.
    Demirag, F.
    Zeren, H.
    Allanoos, R.
    Gibbs, A.
    Cagle, P. T.
    MODERN PATHOLOGY, 2008, 21 : 339A - 340A
  • [34] A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF
    Hashemi, J
    Lindström, MS
    Asker, C
    Platz, A
    Hansson, J
    Wiman, KG
    CANCER LETTERS, 2002, 180 (02) : 211 - 221
  • [35] UVB-induced decrease of p16/CDKN2A expression in skin cancer patients
    Krähn, G
    Leiter, U
    Udart, M
    Kaskel, P
    Peter, RU
    PIGMENT CELL RESEARCH, 2001, 14 (03): : 201 - 205
  • [36] Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
    Csepregi, Antal
    Ebert, Matthias P. A.
    Roecken, Christoph
    Schneider-Stock, Regine
    Hoffmann, Juliane
    Schulz, Hans-Ulrich
    Roessner, Albert
    Malfertheiner, Peter
    BMC CANCER, 2010, 10
  • [37] Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
    Antal Csepregi
    Matthias PA Ebert
    Christoph Röcken
    Regine Schneider-Stock
    Juliane Hoffmann
    Hans-Ulrich Schulz
    Albert Roessner
    Peter Malfertheiner
    BMC Cancer, 10
  • [38] CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients
    Bradly, Dawn P.
    Gattuso, Paolo
    Pool, Mark
    Basu, Sanjib
    Liptay, Michael
    Bonomi, Philip
    Buckingham, Lela
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (04) : 207 - 213
  • [39] Homozygous deletion of CDKN2A (p16/p14) in neuroblastomas.
    Thompson, PM
    Maris, JM
    Hogarty, MD
    Seeger, RC
    Reynolds, CP
    Brodeur, GM
    White, PS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A327 - A327
  • [40] Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development
    Bruno, William
    Andreotti, Virginia
    Bisio, Alessandra
    Pastorino, Lorenza
    Fornarini, Giuseppe
    Sciallero, Stefania
    Bianchi-Scarra, Giovanna
    Inga, Alberto
    Ghiorzo, Paola
    PLOS ONE, 2017, 12 (12):
12345